Thursday, July 12, 2012

Investopedia: Hi-Tech Pharmacal An Under-Followed Name Worth Following

Due to the seemingly insatiable appetites of companies like Teva (NYSE:TEVA), Mylan (Nasdaq:MYL) and Watson (NYSE:WPI), there aren't nearly as many independent publicly-traded generic drug companies as there used to be. While scarcity value alone is not a good argument for considering Hi-Tech Pharmacal (Nasdaq:HITK), this company's focus on higher-barrier products and over-the-counter (OTC) cold and cough business, coupled with little sell-side support, could make it a potential hidden gem at some point.

Continue here:
http://stocks.investopedia.com/stock-analysis/2012/Hi-Tech-Pharmacal-An-Under-Followed-Name-Worth-Following-HITK-PRX-TEVA-WCRX0712.aspx

No comments: